CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Ardena acquires Syntagon and strengthens API offering

Contract development and manufacturing organisation (CDMO) Ardena has acquired Syntagon, a leading contract manufacturer of novel active pharmaceutical ingredients (...
Continue Reading →
News

Eisai, Nichi-Iko Pharma enters strategic partnership

Both companies will promote cooperation in building Eisai's Total Inclusive Ecosystem as well as collaboration on the active pharmaceutical ingredient (API) busi...
Continue Reading →
News

Ardena acquires ChemConnection adding API expertise

  Contract development and manufacturing organisation (CDMO) Ardena has acquired ChemConnection, a leading contract manufacturer of novel active pharmaceutical ...
Continue Reading →
SMi Presents their 2nd Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)
Uncategorised

SMi Presents their 2nd Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)

Date: 21st – 22nd May 2018 Workshop: 23rd May 2018 Location: Holiday Inn, Kensington Forum, London, UK Website: www.highlypotentapi.com/ipi About HPAPI SMi is deligh...
Continue Reading →
News

Hospital-owned generics initiative unlikely to benefit the CMO industry, says GlobalData

A recently-announced plan to establish a not-for-profit generic pharmaceutical company is unlikely to be a boon to the contract manufacturing organization (CMO) indu...
Continue Reading →
News

Saneca Pharma strengthens team with new sales director

Slovakia-based contract development and manufacturing organization (CDMO) Saneca Pharma has strengthened its team with the appointment of a new CDMO sales director a...
Continue Reading →
News

STA Pharmaceutical Sees Rapid Growth in MAH Programs in China

STA Pharmaceutical (STA) – a China-based global API and Drug Product CDMO – reports that it has seen a rapid uptake in companies with intent to market their products...
Continue Reading →
News

Leon-nanodrugs Congratulates its Partner MJR Pharmjet on Receiving Prestigious CPhI Award 2017 for Highly Innovative MicroJet Reactor Technology

The CPhI Pharma Awards are among the most prestigious recognitions within the pharmaceutical industry. MJR PharmJet, partner ofleon-nanodrugs GmbH in drug developmen...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026